NCT03642522
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Non-Invasive Neurostimulation Therapies lab, University of British Columbia Vancouver, British Columbia, Canada
Clinical trial condition
Depressive Disorder, Major
Explore clinical trials studying Depressive Disorder, Major. Study availability and eligibility vary by location and protocol.
2,300 public trials
326 recruiting studies
Depressive Disorder, Major trial results
NCT02371980
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
- Locations
-
- NoesisPharma Phoenix, Arizona, United States
- SW Biomedical Research, LLC Tucson, Arizona, United States
- CNS Research Science, Inc. Cerritos, California, United States
- Collaborative Neuroscience Network, LLC Garden Grove, California, United States
NCT01110902
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- University of Alabama at Birmingham, Department of Psychiatry Birmingham, Alabama, United States
- ATP Clinical Research Costa Mesa, California, United States
- Valley Clinical Research El Centro, California, United States
- Collaborative Neuroscience Network Garden Grove, California, United States
NCT00463242
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site National City, California, United States
- Novartis Investigative Site Orange, California, United States
- Novartis Investigative Site Pasadena, California, United States
Completed
Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
NCT00411099
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Scottsdale, Arizona, United States
- Novartis Investigative Site Little Rock, Arkansas, United States
- Novartis Investigative Site Cerritos, California, United States
- Novartis Investigative Site El Centro, California, United States
NCT01110889
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Birmingham Psychiatry Birmingham, Alabama, United States
- Southwestern Research Institute Beverly Hills, California, United States
- Pharmacology Research Institute Encino, California, United States
- Mood & Anxiety Research Fresno, California, United States
NCT00467402
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Peoria, Arizona, United States
- Novartis Investigative Site Tucson, Arizona, United States
- Novartis Investigative Site Beverly Hills, California, United States
NCT04679753
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- SynapseTMS Yorkton, Saskatchewan, Canada
Completed
Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
NCT00411242
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Mesa, Arizona, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Oceanside, California, United States
- Novartis Investigative Site San Diego, California, United States
NCT03446846
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
- Locations
-
- Woodland International Research Group, LLC Little Rock, Arkansas, United States
- Collaborative Neuroscience Network, LLC Garden Grove, California, United States
- Collaborative Neuroscience Network, LLC Torrance, California, United States
- Pacific Clinical Research Medical Group Upland, California, United States